Filings/5493002YR9VC/IR

Ascelia Pharma AB IR

annual report · 2025-12-31

Annual Report 2025: Orviglance NDA submitted to the FDA, PDUFA-date set for July 2026

Source document

Issuer site
Loading document…
Annual Report 2025: Orviglance NDA submitted to the FDA, PDUFA-date set for July 2026 — Ascelia Pharma AB